EHRA Premium Access

Complications of cardiac interventions during NOAC therapy

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Presentation

About the speaker

Doctor Damian Huber

Innsbruck (Austria)
0 follower

28 more presentations in this session

Epworth sleepness scale and Berlin questionnaire: A comparison in a Tunisian population with non valvular atrial fibrillation

Speaker: Doctor S. Ouali (Tunis, TN)

Thumbnail

Hypertension and atrial fibrillation: an association that increases the risk of developing obstructive sleep apnea in a Tunisian population

Speaker: Doctor S. Ouali (Tunis, TN)

Thumbnail

Left atrial pressure correlates with atrial sphericity but not with the degree of atrial dilatation and scar burden, in patients who underwent pulmonary vein isolation.

Speaker: Doctor A. Margulescu (Swansea, GB)

Thumbnail

AF type and low voltage areas: biomarkers distinguish AF progression phenotypes

Speaker: Associate Professor J. Kornej (Boston, US)

Thumbnail

Triple therapy is superior to dual anti-platelet therapy in atrial fibrillation patients experiencing acute myocardial infarction with percutaneous coronary intervention

Speaker: Associate Professor K. Lee (Gwangju, KR)

Thumbnail

Access the full session

Poster session 1 - Atrial fibrillation - Clinical

Speakers: Doctor D. Huber, Doctor S. Ouali, Doctor S. Ouali, Doctor A. Margulescu, Associate Professor J. Kornej...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk